A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain Removal (NCT02151058) | Clinical Trial Compass
CompletedNot Applicable
A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain Removal
United States227 participantsStarted 2014-06
Plain-language summary
The whitening action of an investigative hydrogen peroxide/sodium fluoride containing mouth rinse will be evaluated through stain removal using mean Lobene Stain Index over 14 days compared to a currently marketed hydrogen peroxide containing whitening mouth rinse (Crest® 3D White Multi-Care Whitening Rinse, Glamorous White, Fresh Mint). A currently marketed toothpaste (Colgate® Cavity Protection) will be included as the negative control in order to compare to brushing alone.
225 healthy volunteers will be enrolled in this two week study. Volunteers who qualify to be in this study will have an equal chance of being assigned to one of the three treatment groups. Volunteers will have a total of 5 clinic visits including 1) screening, 2) baseline 3) Day 4 (after 3 days of use), Day 8 (after 7 days of use) and Day 15 (after 14 days of use). Volunteers will maintain a diary at home to record each treatment use. Examinations for oral hard/soft tissue assessment and extrinsic tooth stain after the subject brushes with water and floss will be completed at Baseline and repeated at Clinic Visits 3, 4, and 5, which are on Days 4, 8 and 15 post baseline (i.e., after 3, 7, and 14 days of product use).
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 18 - 65 years.
✓. Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates) based upon research site personnel's assessment;
✓. Able to provide written informed consent;
✓. Male or non-pregnant, non-lactating female (self-reported)
✓. Male and female subjects with reproductive potential must agree to practice a medically acceptable form of birth control during the study and for 30 days following the last dose of investigational product
✓. Medically acceptable forms of birth control that may be used by the subject and/or his/her partner
✓. Able to read and understand the local language;
✓. Able to follow study procedures;
Exclusion criteria
✕. Suspected alcohol or substance abuse (e.g., amphetamines, benzodiazepines, cocaine, and marijuana) opiates.
What they're measuring
1
Lobene Stain Index Composite Score at Day 15
Timeframe: 15 Days
Trial details
NCT IDNCT02151058
SponsorJohnson & Johnson Consumer and Personal Products Worldwide
✕. Males with a pregnant partner or a partner who is currently trying to become pregnant.
✕. Known sensitivity or history of significant adverse effects to any of the investigational products.
✕. Significant unstable or uncontrolled medical condition which may interfere with a subject's participation in the study.
✕. Participated in tooth stain removal trials in the least 3 months
✕. Participation in any other clinical study within 30 days of Visit 1.
✕. Subjects who are related to those persons involved directly or indirectly with the conduct of this study (i.e., principal investigator, sub-investigators, study coordinators, other site personnel, employees of Johnson \& Johnson subsidiaries, contractors of Johnson \& Johnson, and the families of each).